Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 30, 1998
[Radiochemotherapy and radiosensitization for locally advanced non-small-cell bronchial cancer]E Quoix, L Moreau, J P OsterClinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 6, 2002
The allergen profile of ash (Fraxinus excelsior) pollen: cross-reactivity with allergens from various plant speciesV Niederberger, A Purohit, J P Oster, et al.Lung Cancer (Amsterdam, Netherlands)|November 22, 2000
Comparative prognostic value of lactate dehydrogenase and neuron-specific enolase in small-cell lung cancer patients treated with platinum-based chemotherapyE Quoix, A Purohit, M Faller-Beau, et al.Annales D'Oto-Laryngologie Et De Chirurgie Cervico Faciale : Bulletin De La Societe D'Oto-Laryngologie Des Hopitaux De Paris|October 27, 2001
[Nasosinusal sarcoidosis: 13 cases]J J Braun, P Bourjat, J P Oster, et al.The European Respiratory Journal|November 27, 2002
Nerve growth factor levels and localisation in human asthmatic bronchiC Olgart Höglund, F de Blay, J P Oster, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 10, 2000
Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French populationG Pauli, A Purohit, J P Oster, et al.Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|August 8, 2001
Skin testing with wild-type recombinant birch pollen allergens and hypoallergenic modified moleculesG Pauli, A Purohit, J P Oster, et al.The Journal of Allergy and Clinical Immunology|May 1, 1996
Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: diagnostic value for birch pollen and associated allergiesG Pauli, J P Oster, P Deviller, et al.Journal of Investigational Allergology & Clinical Immunology|April 2, 2019
Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life StudyA Tiotiu, J P Oster, P R Roux, et al.Revue Des Maladies Respiratoires|October 15, 2021
[Severe adult asthma and treatment adherence: Results of the FASE-CPHG study]C Maurer, C Raherison-Semjen, B Lemaire, et al.Pageof 2